therapeutic landscape for patients with her2-positive breast cancer with active brain metastases
Published 2 years ago • 285 plays • Length 5:37Download video MP4
Download video MP3
Similar videos
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
3:15
brain metastases in her2 breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
0:53
the latest news on the management of breast cancer patients with brain metastases
-
1:24
potential treatment approaches for breast cancer with brain metastases
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
1:22
advancing cancer therapeutics for brain metastases
-
1:56
treating her2 breast cancer with brain metastases
-
3:06
trastuzumab deruxtecan effective against brain metastases in her2-positive breast cancer
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
1:42
treatment landscape for her2-positive breast cancer
-
1:30
dr. czerniecki on treatment options for patients with her2 brain metastases
-
0:38
treatment updates for breast cancer with brain metastases
-
3:05
pi3k inhibitors for the treatment of brain metastases in her2-negative breast cancer
-
1:23
tuxedo-1: qol and neurocognitive function in her2-positive bc w/ brain metastasis treated with t-dxd
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
8:00
a look at the therapeutic landscape for metastatic breast cancer
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer